1.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: Over 18
Sponsor: NCI
Protocol IDs: RPCI-I-83706, NCT00470431, I 83706
|
|
2.
|
Phase: Phase II
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: CPMC-IRB-6850, NCI-P97-0109
|
|
3.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PCI-9304, NCI-V93-0286
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-RP-0203, PCI-00-034, NCT00054522
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-RP-0212, NCT00084864
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 to 90
Sponsor: Other
Protocol IDs: PROS0021, 95804, NCT00383487, PROS0021, NCT00383487
|
|
7.
|
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: RPCI-I-65405, I 65405, NCT00524589
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 011-017, NCT00536770
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000445077, OHSU-GIM-02007-L, OHSU-1104, NCT00238199
|
|
10.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068720, OHSU-6218, OHSU-HOR-00059-L, NCI-G01-1963, NCT00017576
|
|
11.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 100
Sponsor: NCI, Other
Protocol IDs: CDR0000441172, OHSU-8451, OHSU-VA-IRB-9451, NCT00182741
|
|
12.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067041, OHSU-5231, OCC-HOR-98068-L, NCI-V99-1542, NCT00004043
|
|
13.
|
Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000433508, P30CA072720, CINJ-080404, CINJ-4901, CINJ-NJ3803, NCT00118066
|
|
14.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: OHSU-4673, OCC-ONC-97079-L, NCI-V98-1381
|
|
15.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-99073, NCI-H00-0048, NCT00004928
|
|
16.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: PCI-97-004, PCI-IRB-970532, NCI-G00-1885, NCT00008086
|
|
17.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: PCI-98019, PCI-IRB-980542, NCI-G00-1901, NCT00009802
|
|
18.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: PCI-99044, PCI-IRB-990606, NCT00010231
|
|
19.
|
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: RPCI-RPC-0207, ZENECA-1839US/0295, NCT00084708
|
|
20.
|
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: RPCI-I-33204, NCT00238225
|
|
21.
|
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 45 and over
Sponsor: Other
Protocol IDs: PROS0022, 97408, NCT00482157, PROS0022, NCT00482157
|
